Univ Missouri Research Reactor Center, based in U.S.A, is a pharmaceutical company.
One of their notable products is SODIUM IODIDE I-131 SOLUTION, with a corresponding US DMF Number 32854.
Remarkably, this DMF maintains an Active status since its submission on August 10, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 12, 2019, and payment made on August 29, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II